Brief: 3Sbio Gets Acceptance Of Marketing Authorization Application For Ampholipad In Mainland China

3SBio

26/08/2020 16:33

Aug 26 (Reuters) - 3SBio Inc  1530.HK :
    * GETS ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION FOR
AMPHOLIPAD™ IN MAINLAND CHINA
    * WILL COMMERCIALIZE PRODUCT IN MAINLAND CHINA

Source text for Eikon:  ID:nHKS9NYcf8 
Further company coverage:  1530.HK 

 ((Reuters.Briefs@thomsonreuters.com;))